Articles by D. J. Diekema (6)

In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model

D. Andes, D. J. Diekema, M. A. Pfaller, R. A. Prince, K. Marchillo, J. Ashbeck and J. Hou

Antimicrobial Agents and Chemotherapy 52 ( 2 ): 539 - 550 , 2008

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

D. R. Andes, D. J. Diekema, M. A. Pfaller, K. Marchillo and J. Bohrmueller

Antimicrobial Agents and Chemotherapy 52 ( 10 ): 3497 - 3503 , 2008

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. A. Pfaller, L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar and D. J. Diekema

Journal of Clinical Microbiology 46 ( 1 ): 150 - 156 , 2008

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

M. A. Pfaller, S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis and D. J. Diekema

Journal of Clinical Microbiology 46 ( 8 ): 2568 - 2572 , 2008

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

M. A. Pfaller, D. J. Diekema, L. Ostrosky-Zeichner, J. H. Rex, B. D. Alexander, D. Andes, S. D. Brown, V. Chaturvedi, M. A. Ghannoum, C. C. Knapp, D. J. Sheehan and T. J. Walsh

Journal of Clinical Microbiology 46 ( 8 ): 2620 - 2629 , 2008

Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

M. A. Pfaller, L. B. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar and D. J. Diekema

Journal of Clinical Microbiology 46 ( 11 ): 3585 - 3590 , 2008